McMaster Textbook of Internal Medicine
Interviews
VTE
An association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardi...

An association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction

2015-06-05

James Douketis

See also

Management tips for use of the new oral anticoagulants Prof. James Douketis, from McMaster University, Canada, addresses real-world "what if" scenarios for managing patients on NOACs, such as how to choose the right NOAC, determine if a patient needs a procedure or surgery, understand safety of concomitant drugs, and prescribe off-label use of NOACs.
Approaching a patient on novel oral anticoagulants who develops bleeding or requires an urgent surgery How to approach a patient treated with novel oral anticoagulants who develops bleeding or in whom an urgent surgery is necessary?
Assessing the risk of recurrent thrombosis and the Vienna Prediction Model How can we adequately assess the risk of recurrent thrombosis? What is the Vienna Prediction Model?

We would love to hear from you

Comments, mistakes, suggestions?